ID ZFP57_HUMAN Reviewed; 452 AA. AC Q9NU63; B0S894; B0V254; B2RXJ7; Q5SSB1; DT 26-JUN-2007, integrated into UniProtKB/Swiss-Prot. DT 26-JUN-2007, sequence version 2. DT 27-MAR-2024, entry version 172. DE RecName: Full=Zinc finger protein 57 homolog {ECO:0000305}; DE Short=Zfp-57; DE AltName: Full=Zinc finger protein 698; GN Name=ZFP57 {ECO:0000312|HGNC:HGNC:18791}; Synonyms=C6orf40, ZNF698; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-284. RX PubMed=14574404; DOI=10.1038/nature02055; RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., RA Rogers J., Beck S.; RT "The DNA sequence and analysis of human chromosome 6."; RL Nature 425:805-811(2003). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP FUNCTION, AND DEVELOPMENTAL STAGE. RX PubMed=30602440; DOI=10.1101/gad.320069.118; RA Takahashi N., Coluccio A., Thorball C.W., Planet E., Shi H., Offner S., RA Turelli P., Imbeault M., Ferguson-Smith A.C., Trono D.; RT "ZNF445 is a primary regulator of genomic imprinting."; RL Genes Dev. 33:49-54(2019). RN [4] RP VARIANTS TNDM1 HIS-166; ASN-193 AND ASP-374, AND FUNCTION. RX PubMed=18622393; DOI=10.1038/ng.187; RA Mackay D.J.G., Callaway J.L.A., Marks S.M., White H.E., Acerini C.L., RA Boonen S.E., Dayanikli P., Firth H.V., Goodship J.A., Haemers A.P., RA Hahnemann J.M.D., Kordonouri O., Masoud A.F., Oestergaard E., Storr J., RA Ellard S., Hattersley A.T., Robinson D.O., Temple I.K.; RT "Hypomethylation of multiple imprinted loci in individuals with transient RT neonatal diabetes is associated with mutations in ZFP57."; RL Nat. Genet. 40:949-951(2008). CC -!- FUNCTION: Transcription regulator required to maintain maternal and CC paternal gene imprinting, a process by which gene expression is CC restricted in a parent of origin-specific manner by epigenetic CC modification of genomic DNA and chromatin, including DNA methylation. CC Acts by controlling DNA methylation during the earliest multicellular CC stages of development at multiple imprinting control regions (ICRs) CC (PubMed:18622393, PubMed:30602440). Acts together with ZNF445, but CC ZNF445 seems to be the major factor in human early embryonic imprinting CC maintenance. In contrast, in mice, ZFP57 plays the predominant role in CC imprinting maintenance (PubMed:30602440). Required for the CC establishment of maternal methylation imprints at SNRPN locus. Acts as CC a transcriptional repressor in Schwann cells. Binds to a 5'-TGCCGC-3' CC consensus sequence and recognizes the methylated CpG within this CC element (By similarity). {ECO:0000250|UniProtKB:Q8C6P8, CC ECO:0000269|PubMed:18622393, ECO:0000269|PubMed:30602440}. CC -!- INTERACTION: CC Q9NU63-3; Q96Q77: CIB3; NbExp=3; IntAct=EBI-12879708, EBI-10292696; CC Q9NU63-3; Q92997: DVL3; NbExp=3; IntAct=EBI-12879708, EBI-739789; CC Q9NU63-3; P50402: EMD; NbExp=3; IntAct=EBI-12879708, EBI-489887; CC Q9NU63-3; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-12879708, EBI-2556193; CC Q9NU63-3; Q13064: MKRN3; NbExp=3; IntAct=EBI-12879708, EBI-2340269; CC Q9NU63-3; P40692: MLH1; NbExp=3; IntAct=EBI-12879708, EBI-744248; CC Q9NU63-3; O15160: POLR1C; NbExp=3; IntAct=EBI-12879708, EBI-1055079; CC Q9NU63-3; Q5VVQ6: YOD1; NbExp=3; IntAct=EBI-12879708, EBI-2510804; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:30602440}. Note=Binds CC various differentially methylated regions (DMR). CC {ECO:0000269|PubMed:30602440}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q9NU63-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9NU63-2; Sequence=VSP_026329, VSP_026330; CC Name=3; CC IsoId=Q9NU63-3; Sequence=VSP_036659, VSP_026330; CC -!- DEVELOPMENTAL STAGE: In contrast to mice, transcripts are undetectable CC in the oocyte and during the earliest stages of embryonic development, CC increasing only after zygotic genome activation. CC {ECO:0000269|PubMed:30602440}. CC -!- DOMAIN: The KRAB domain is required for function as transcriptional CC repressor. {ECO:0000250|UniProtKB:Q8C6P8}. CC -!- DOMAIN: Zinc fingers 3 and 4 mediate recognition of the target element, CC ZF3 interacting with the 5' half (TGC) and ZF4 interacting with the 3' CC half (CGC). {ECO:0000250|UniProtKB:Q8C6P8}. CC -!- DISEASE: Diabetes mellitus, transient neonatal, 1 (TNDM1) [MIM:601410]: CC An autosomal dominant form of diabetes mellitus defined by the onset of CC mild-to-severe hyperglycemia within the first month of life. In about CC half of the neonates, diabetes is transient and resolves at a median CC age of 3 months, whereas the rest have a permanent form of diabetes. CC {ECO:0000269|PubMed:18622393}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein CC family. ZFP57 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL050328; CAB89275.2; -; Genomic_DNA. DR EMBL; AL645936; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL669813; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL929591; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BX120002; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BX927250; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CR388408; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CR759766; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CR936483; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC157878; AAI57879.1; -; mRNA. DR CCDS; CCDS43436.2; -. [Q9NU63-3] DR RefSeq; NP_001103279.2; NM_001109809.2. [Q9NU63-3] DR AlphaFoldDB; Q9NU63; -. DR SMR; Q9NU63; -. DR BioGRID; 131375; 14. DR IntAct; Q9NU63; 9. DR MINT; Q9NU63; -. DR STRING; 9606.ENSP00000418259; -. DR iPTMnet; Q9NU63; -. DR PhosphoSitePlus; Q9NU63; -. DR BioMuta; ZFP57; -. DR DMDM; 150416327; -. DR EPD; Q9NU63; -. DR MassIVE; Q9NU63; -. DR MaxQB; Q9NU63; -. DR PeptideAtlas; Q9NU63; -. DR ProteomicsDB; 82655; -. [Q9NU63-1] DR ProteomicsDB; 82656; -. [Q9NU63-2] DR ProteomicsDB; 82657; -. [Q9NU63-3] DR Antibodypedia; 26080; 231 antibodies from 20 providers. DR DNASU; 346171; -. DR Ensembl; ENST00000376883.2; ENSP00000366080.2; ENSG00000204644.10. [Q9NU63-3] DR Ensembl; ENST00000383628.6; ENSP00000373124.2; ENSG00000206510.9. [Q9NU63-2] DR Ensembl; ENST00000416974.5; ENSP00000396462.1; ENSG00000223858.7. [Q9NU63-2] DR Ensembl; ENST00000435906.5; ENSP00000412932.1; ENSG00000226858.7. [Q9NU63-2] DR Ensembl; ENST00000437216.5; ENSP00000398086.1; ENSG00000223852.7. [Q9NU63-2] DR Ensembl; ENST00000446005.5; ENSP00000394222.1; ENSG00000234669.7. [Q9NU63-2] DR Ensembl; ENST00000448114.5; ENSP00000409118.1; ENSG00000232099.7. [Q9NU63-2] DR Ensembl; ENST00000547542.2; ENSP00000447492.2; ENSG00000223852.7. [Q9NU63-1] DR Ensembl; ENST00000547911.2; ENSP00000449556.2; ENSG00000234669.7. [Q9NU63-1] DR Ensembl; ENST00000548001.2; ENSP00000446541.2; ENSG00000232099.7. [Q9NU63-1] DR Ensembl; ENST00000548337.1; ENSP00000449407.1; ENSG00000232099.7. [Q9NU63-3] DR Ensembl; ENST00000548574.1; ENSP00000446798.1; ENSG00000223852.7. [Q9NU63-3] DR Ensembl; ENST00000548769.1; ENSP00000448351.1; ENSG00000206510.9. [Q9NU63-3] DR Ensembl; ENST00000549167.1; ENSP00000449230.1; ENSG00000226858.7. [Q9NU63-3] DR Ensembl; ENST00000549501.2; ENSP00000447698.2; ENSG00000226858.7. [Q9NU63-1] DR Ensembl; ENST00000552809.1; ENSP00000450279.1; ENSG00000223858.7. [Q9NU63-3] DR Ensembl; ENST00000552898.2; ENSP00000450397.2; ENSG00000223858.7. [Q9NU63-1] DR Ensembl; ENST00000552987.2; ENSP00000448634.2; ENSG00000206510.9. [Q9NU63-1] DR Ensembl; ENST00000553137.1; ENSP00000447495.1; ENSG00000234669.7. [Q9NU63-3] DR GeneID; 346171; -. DR KEGG; hsa:346171; -. DR MANE-Select; ENST00000376883.2; ENSP00000366080.2; NM_001109809.5; NP_001103279.2. [Q9NU63-3] DR UCSC; uc011dlw.2; human. [Q9NU63-1] DR AGR; HGNC:18791; -. DR CTD; 346171; -. DR DisGeNET; 346171; -. DR GeneCards; ZFP57; -. DR GeneReviews; ZFP57; -. DR HGNC; HGNC:18791; ZFP57. DR HPA; ENSG00000204644; Group enriched (brain, heart muscle). DR MalaCards; ZFP57; -. DR MIM; 601410; phenotype. DR MIM; 612192; gene. DR neXtProt; NX_Q9NU63; -. DR OpenTargets; ENSG00000204644; -. DR Orphanet; 99886; Transient neonatal diabetes mellitus. DR PharmGKB; PA134937821; -. DR VEuPathDB; HostDB:ENSG00000204644; -. DR GeneTree; ENSGT00390000002599; -. DR HOGENOM; CLU_002678_0_7_1; -. DR InParanoid; Q9NU63; -. DR OMA; HQQTHWR; -. DR OrthoDB; 5265384at2759; -. DR PhylomeDB; Q9NU63; -. DR TreeFam; TF337947; -. DR PathwayCommons; Q9NU63; -. DR SignaLink; Q9NU63; -. DR BioGRID-ORCS; 346171; 31 hits in 1164 CRISPR screens. DR GeneWiki; ZFP57; -. DR GenomeRNAi; 346171; -. DR Pharos; Q9NU63; Tbio. DR PRO; PR:Q9NU63; -. DR Proteomes; UP000005640; Chromosome 6. DR RNAct; Q9NU63; Protein. DR Bgee; ENSG00000204644; Expressed in primordial germ cell in gonad and 86 other cell types or tissues. DR ExpressionAtlas; Q9NU63; baseline and differential. DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. DR GO; GO:0003682; F:chromatin binding; IDA:UniProtKB. DR GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central. DR GO; GO:0141068; P:autosome genomic imprinting; IMP:UniProtKB. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central. DR CDD; cd07765; KRAB_A-box; 1. DR Gene3D; 6.10.140.140; -; 1. DR Gene3D; 3.30.160.60; Classic Zinc Finger; 6. DR InterPro; IPR001909; KRAB. DR InterPro; IPR036051; KRAB_dom_sf. DR InterPro; IPR036236; Znf_C2H2_sf. DR InterPro; IPR013087; Znf_C2H2_type. DR PANTHER; PTHR23232; KRAB DOMAIN C2H2 ZINC FINGER; 1. DR PANTHER; PTHR23232:SF90; KRAB DOMAIN-CONTAINING PROTEIN; 1. DR Pfam; PF01352; KRAB; 1. DR Pfam; PF00096; zf-C2H2; 6. DR SMART; SM00349; KRAB; 1. DR SMART; SM00355; ZnF_C2H2; 7. DR SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 4. DR SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1. DR PROSITE; PS50805; KRAB; 1. DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 6. DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7. DR Genevisible; Q9NU63; HS. PE 1: Evidence at protein level; KW Alternative splicing; Developmental protein; Diabetes mellitus; KW Disease variant; DNA-binding; Metal-binding; Nucleus; Reference proteome; KW Repeat; Repressor; Transcription; Transcription regulation; Zinc; KW Zinc-finger. FT CHAIN 1..452 FT /note="Zinc finger protein 57 homolog" FT /id="PRO_0000291964" FT DOMAIN 16..88 FT /note="KRAB" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00119" FT ZN_FING 91..113 FT /note="C2H2-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 119..141 FT /note="C2H2-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 147..169 FT /note="C2H2-type 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 175..197 FT /note="C2H2-type 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 300..322 FT /note="C2H2-type 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 328..350 FT /note="C2H2-type 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 356..378 FT /note="C2H2-type 7; degenerate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT REGION 410..452 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT SITE 185 FT /note="Crucial for 5-methylcytosine recognition" FT /evidence="ECO:0000250" FT VAR_SEQ 1..13 FT /note="MAAGEPRSLLFFQ -> MFEQLKPIEPRDCWREARVKK (in isoform FT 2)" FT /evidence="ECO:0000305" FT /id="VSP_026329" FT VAR_SEQ 1..13 FT /note="MAAGEPRSLLFFQ -> MFEQLKPIEPVQKTLPWVGEVAATLQEAMKRDCWR FT EARVKK (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_036659" FT VAR_SEQ 78 FT /note="E -> EFVHLPNTEGLSEGKKKELREQHPSLRDEGTSDDKVFLACRGAGQCP FT LSAPAGTMDR (in isoform 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_026330" FT VARIANT 114 FT /note="N -> S (in dbSNP:rs9461544)" FT /id="VAR_032902" FT VARIANT 166 FT /note="R -> H (in TNDM1; dbSNP:rs199589695)" FT /evidence="ECO:0000269|PubMed:18622393" FT /id="VAR_054771" FT VARIANT 193 FT /note="H -> N (in TNDM1; dbSNP:rs78378398)" FT /evidence="ECO:0000269|PubMed:18622393" FT /id="VAR_054772" FT VARIANT 284 FT /note="D -> V (in dbSNP:rs2535241)" FT /evidence="ECO:0000269|PubMed:14574404" FT /id="VAR_032903" FT VARIANT 374 FT /note="H -> D (in TNDM1; dbSNP:rs79020217)" FT /evidence="ECO:0000269|PubMed:18622393" FT /id="VAR_054773" FT CONFLICT 151 FT /note="L -> F (in Ref. 2; AAI57879)" FT /evidence="ECO:0000305" SQ SEQUENCE 452 AA; 51919 MW; 6B285B7FB9ABB3BA CRC64; MAAGEPRSLL FFQKPVTFED VAVNFTQEEW DCLDASQRVL YQDVMSETFK NLTSVARIFL HKPELITKLE QEEEQWRETR VLQASQAGPP FFCYTCGKCF SRRSYLYSHQ FVHNPKLTNS CSQCGKLFRS PKSLSYHRRM HLGERPFCCT LCDKTYCDAS GLSRHRRVHL GYRPHSCSVC GKSFRDQSEL KRHQKIHQNQ EPVDGNQECT LRIPGTQAEF QTPIARSQRS IQGLLDVNHA PVARSQEPIF RTEGPMAQNQ ASVLKNQAPV TRTQAPITGT LCQDARSNSH PVKPSRLNVF CCPHCSLTFS KKSYLSRHQK AHLTEPPNYC FHCSKSFSSF SRLVRHQQTH WKQKSYLCPI CDLSFGEKEG LMDHWRGYKG KDLCQSSHHK CRVILGQWLG FSHDVPTMAG EEWKHGGDQS PPRIHTPRRR GLREKACKGD KTKEAVSILK HK //